‘One-size-fits-all’ treatment targets harm frail older patients with diabetes

HbA1c targets that ignore differences in the physiology of older patients put them at risk of severe hypoglycaemia, harm and death.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research